Business Wire

Gamma Waves Launches: Playing Tomorrow’s Game Today

24.4.2026 12:15:00 EEST | Business Wire | Press release

Share

Gamma Waves, a permanent capital investment company, with the ambition to build an innovative sport-focused platform, launches today. Based in Amsterdam, the company was founded by Andrea Agnelli, Rocco Benetton and Giorgio Chiellini, with the aim of creating new value across:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424892627/en/

Gamma Waves Partners launched today, here is the team, including founders, Andrea Agnelli, Rocco Benetton and Giorgio Chiellini, along with Chief Investment Officer, Kyang Yung

  • Sport IPs (Intellectual Properties): assets in globally captivating sectors such as basketball, hockey, cricket, tennis, baseball, rugby, etc., offering unique reach and credibility;
  • Sports Tech: high-quality sports technology products that often struggle to scale because, on their own, they lack sufficient incentives and distribution to break through alongside IPs.

Gamma Waves aims to bridge this gap by building a multi-franchise platform and using it, selectively and responsibly, as an accelerator for the growth of the Sports Tech portfolio.

A simple belief underpins this endeavour. The game has changed and the next era of sports will be shaped by those who can connect what has historically lived apart. A simple game became a global product; today it is becoming digital, immersive and personalised, driven by new generations, new formats, and a world in which athletes, creators and communities shape attention every day.

“Sport is one of the few things that people truly feel,” said Andrea Agnelli, Founder of Gamma Waves, “but the way people experience it is dramatically changing. Tomorrow’s game is unconventional and it needs an unconventional approach. Our ambition is to drive innovation while honouring the legacy and cultural significance of sport. In doing so, we aim to create a virtuous cycle of value across both.”

Gamma Waves is deeply rooted in sport and founded on a clear conviction: the most compelling value is created at the intersection of Sports IP and Sports Tech, reshaping how sport is played, consumed and monetised. The firm will take minority stakes in forward-looking competitions, clubs, teams, athletes and emerging formats, while also investing in growth-stage sports-tech companies where adoption is accelerating and impact is measurable: from fan engagement and athlete/team performance to data analytics, AI-automated content production and the connected athlete ecosystem. By linking these investments, Gamma Waves builds a self-reinforcing network: Sports IP-led insight helps select and accelerate technology, and technology, tested, scaled and refined alongside real partners, strengthens IP performance and growth, supported by hands-on execution, aligned incentives, board-level partnership and innovation-driven KPIs.

A different kind of ownership mindset

Gamma Waves will not chase hype cycles. It will build patiently, asset by asset, partnership by partnership, with a long horizon. Investment decisions will be driven by the Chief Investment Officer, Kyang Yung, and selected young talented professionals.

“I am excited to join Andrea, Rocco and Giorgio — three highly complementary individuals whose combined legacy across Sports IP is exceptional. Gamma Waves brings together owners, operators and athletes around the same table, which is powerful and rare. As a tech-minded growth investor, I see a unique opportunity to apply disciplined capital allocation, governance and scaling expertise to assets that sit at the very heart of global culture,” said Chief Investment Officer, Kyang Yung.

What’s next

Following today’s launch, Gamma Waves will focus on:

  • forming long-term partnerships with forward-looking sports franchises and competition operators,
  • investing in select companies that strengthen how sport is engaged, measured and experienced, and
  • building an operating platform that helps partners play tomorrow’s game today without losing authenticity.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260424892627/en/

Contacts

GAMMA WAVES PARTNERS B.V.
Prinsengracht 769
1017 JZ Amsterdam, The Netherlands
T +31 (0)20 787 1313
www.gammawavespartners.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.gammawavesp
artners.com&esheet=54517716&newsitemid=20260424892627&lan=en-US&anchor=www.gamma
wavespartners.com&index=1&md5=97f94624731a3f2044ada5439b099144
Commercial Register No. 99164272

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye